HUY NGUYEN: Open Payments
NPI 1215178215 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 27 payments from 8 companies in 2025. Trend: 2023 $778 · 2024 $568 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $231 |
| GlaxoSmithKline, LLC. | 9 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $57 |
| Kowa Pharmaceuticals America, Inc. | 2 | $50 |
| PFIZER INC. | 3 | $47 |
| Exact Sciences Corporation | 2 | $38 |
| Novo Nordisk Inc | 1 | $22 |
Products named: TRELEGY ELLIPTA, Kerendia, ZORYVE, VRAYLAR, The Cologuard Plus Collection Kit, NURTEC ODT, Wegovy, ELIQUIS.
Industry payments across LA — which companies pay providers there.
